Hybrid Polysaccharide/Magnetite Microgels for Drug-Free Magnetically Targeted Photothermal Thrombolysis

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cardiovascular Research

Background:

• Cardiovascular diseases are a leading global cause of death, often resulting from thrombus formation (e.g., heart attack, stroke).
• Existing treatments like mechanical thrombectomy and fibrinolytic drugs have limitations in accessibility, efficacy, and safety.
• Local hyperthermia presents a promising alternative mechanism for thrombolysis, targeting multiple clot components.

Purpose of the Study:

• To develop and evaluate a drug-free therapeutic strategy for targeted thrombolysis using magnetically guided hybrid microparticles for photo-thermal therapy.
• To assess the efficacy and biocompatibility of these hybrid microparticles in both in vitro and in vivo models.

Main Methods:

• Hybrid microparticles (HPs) were synthesized using biocompatible materials, combining magnetite nanoparticles (MNPs) within cross-linked dextran microgels.
• The HPs were characterized for size, stability, magnetic properties, and photo-thermal conversion efficiency.
• In vitro photo-thermal thrombolysis was performed, and in vivo studies utilized a murine thrombus model to evaluate clot reduction and safety.

Main Results:

• Synthesized HPs demonstrated injectable size, high colloidal stability, excellent biocompatibility, and efficient magnetic targeting due to strong magnetic macromoments.
• The HPs exhibited a high photo-thermal conversion efficiency of 38%.
• In vitro studies confirmed photo-thermal thrombolysis within a specific temperature window, and in vivo application resulted in a significant 32% reduction of thrombus in a murine model without pharmaceutical intervention.

Conclusions:

• Magnetically coupled magnetite nanoparticles within microgels offer a promising drug-free approach for targeted photo-thermal thrombolysis.
• This strategy demonstrates effective clot reduction in vivo, highlighting its potential as a safer and more accessible alternative to current cardiovascular treatments.